PATRICK ORUWARI: Open Payments
NPI 1952396863 · POTOSI, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 57 payments from 12 companies in 2025. Trend: 2023 $1,245 · 2024 $807 · 2025 $1,333
Food & beverage: $1,233Education: $100
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $374 |
| HARMONY BIOSCIENCES LLC | 8 | $349 |
| ABBVIE INC. | 14 | $182 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Janssen Pharmaceuticals, Inc | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Braeburn Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Alkermes, Inc. | 2 | $35 |
Products named: INGREZZA, WAKIX, VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA, BRIXADI, COBENFY.
Industry payments across MO — which companies pay providers there.
